Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/27004
Full metadata record
DC FieldValueLanguage
dc.contributor.authorModat, M-
dc.contributor.authorBocchetta, M-
dc.contributor.authorDos Santos Canas, L-
dc.contributor.authorCash, D-
dc.contributor.authorOurselin, S-
dc.contributor.editorColliot, O-
dc.date.accessioned2023-08-20T15:01:04Z-
dc.date.available2023-08-20T15:01:04Z-
dc.date.issued2023-07-24-
dc.identifierORCID iD: Martina Bocchetta https://orcid.org/0000-0003-1814-5024-
dc.identifier25-
dc.identifier.citationModat, M. et al. (2023) 'Machine Learning for Alzheimer’s Disease and Related Dementias', in Colliot, O. (ed.) Machine Learning for Brain Disorders. (Neuromethods, vol 197). New York, NY, USA: Humana Press, pp. 807 - 846. doi: 10.1007/978-1-0716-3195-9_25.en_US
dc.identifier.isbn978-1-0716-3194-2 (pbk)-
dc.identifier.isbn978-1-0716-3195-9 (ebk)-
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/27004-
dc.description.abstractCopyright © The Author(s) 2023. Dementia denotes the condition that affects people suffering from cognitive and behavioral impairments due to brain damage. Common causes of dementia include Alzheimer’s disease, vascular dementia, or frontotemporal dementia, among others. The onset of these pathologies often occurs at least a decade before any clinical symptoms are perceived. Several biomarkers have been developed to gain a better insight into disease progression, both in the prodromal and the symptomatic phases. Those markers are commonly derived from genetic information, biofluid, medical images, or clinical and cognitive assessments. Information is nowadays also captured using smart devices to further understand how patients are affected. In the last two to three decades, the research community has made a great effort to capture and share for research a large amount of data from many sources. As a result, many approaches using machine learning have been proposed in the scientific literature. Those include dedicated tools for data harmonization, extraction of biomarkers that act as disease progression proxy, classification tools, or creation of focused modeling tools that mimic and help predict disease progression. To date, however, very few methods have been translated to clinical care, and many challenges still need addressing.en_US
dc.description.sponsorshipMM, LC, and SO research is supported by the Wellcome EPSRC Centre for Medical Engineering at King’s College London (WT 203148/Z/16/Z), EPSRC (EP/T022205/1), the Wellcome Trust (WT 215010/Z/18/Z), the UK Research and Innovation London Medical Imaging and Artificial Intelligence Centre for Value-Based Healthcare, Medical Research Council (MRC), NIHR, Alzheimer’s Society, and the European Union. DMC is supported by the UK Dementia Research Institute which receives its funding from DRI Ltd, funded by the UK Medical Research Council, Alzheimer’s Society and Alzheimer’s Research UK (ARUK-PG2017-1946), the UCL/UCLH NIHR Biomedical Research Centre, and the UKRI Innovation Scholars: Data Science Training in Health and Bioscience (MR/V03863X/1). MB is supported by a Fellowship award from the Alzheimer’s Society, UK (AS-JF-19a-004-517). MB’s work was also supported by the UK Dementia Research Institute which receives its funding from DRI Ltd, funded by the UK Medical Research Council, Alzheimer’s Society, and Alzheimer’s Research UK.en_US
dc.format.mediumPrint-Electronic-
dc.language.isoen_USen_US
dc.publisherHumana Pressen_US
dc.relation.ispartofseriesNeuromethods;vol 197-
dc.rightsCopyright © The Author(s) 2023. Rights and permissions: Open Access. This chapter is licensed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made. The images or other third party material in this chapter are included in the chapter's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the chapter's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subjectdementiaen_US
dc.subjectAlzheimer’s diseaseen_US
dc.subjectcognitive impairmenten_US
dc.subjectmachine learningen_US
dc.subjectdata harmonizationen_US
dc.subjectbiomarkersen_US
dc.subjectimagingen_US
dc.subjectclassificationen_US
dc.subjectdisease progression modelingen_US
dc.titleMachine Learning for Alzheimer’s Disease and Related Dementiasen_US
dc.typeBook chapteren_US
dc.identifier.doihttps://doi.org/10.1007/978-1-0716-3195-9_25-
dc.relation.isPartOfMachine Learning for Brain Disorders-
pubs.publication-statusPublished-
dc.rights.holderThe Author(s)-
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © The Author(s) 2023. Rights and permissions: Open Access. This chapter is licensed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made. The images or other third party material in this chapter are included in the chapter's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the chapter's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.963.15 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons